These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9296849)

  • 1. [Infection of the gastrointestinal tract by cytomegalovirus].
    Coll I; Garau J
    Gastroenterol Hepatol; 1997; 20(6):315-21. PubMed ID: 9296849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects and therapy of infection with cytomegalovirus].
    Reusser P
    Internist (Berl); 1992 Sep; 33(9):593-6. PubMed ID: 1328108
    [No Abstract]   [Full Text] [Related]  

  • 3. How to treat the cytomegalovirus troll.
    Goodgame RW
    Am J Gastroenterol; 1998 Mar; 93(3):293-5. PubMed ID: 9517626
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of cytomegalovirus infection. The Jefferiss Wing Therapeutics and Protocols Group.
    Fisher M; Tomlinson DR; Coker RJ
    Int J STD AIDS; 1995; 6(5):313-9. PubMed ID: 8547410
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus colitis in children with inflammatory bowel disease.
    Ghidini B; Bellaiche M; Berrebi D; Viala J; Hugot JP; Mougenot JF; Munck A; Peuchmaur M; Cezard JP
    Gut; 2006 Apr; 55(4):582-3. PubMed ID: 16531541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytomegalovirus polyradiculomyelopathy in AIDS].
    Jayaweera DT; Cassetti LI; Espinoza L; Lopardo GD; Hansman-Whiteman ML; Scerpella EG
    Medicina (B Aires); 1998; 58(2):135-40. PubMed ID: 9706245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinomyces infection of a cytomegalovirus esophageal ulcer in two patients with acquired immunodeficiency syndrome.
    Poles MA; McMeeking AA; Scholes JV; Dieterich DT
    Am J Gastroenterol; 1994 Sep; 89(9):1569-72. PubMed ID: 8079942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human cytomegalovirus infection].
    Tanaka-Taya K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():528-33. PubMed ID: 15861706
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E; Kallas WM; Fishman JA
    Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Italian Foscarnet GID Study Group.
    Gerna G; Sarasini A; Baldanti F; Percivalle E; Zella D; Revello MG
    Antiviral Res; 1997 Mar; 34(1):39-50. PubMed ID: 9107384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of gastrointestinal infections caused by cytomegalovirus.
    Ishida T; Imai K
    J Gastroenterol; 2003; 38(7):712-3. PubMed ID: 12903668
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of cytomegalovirus disease recurrence in an HIV-1-positive patient.
    Kottaridi C; Ploumidis G; Grapsas E; Feretis C; Benakis P; Filalithis P; Bouzarelou D; Nasioulas G
    J Gastroenterol; 2003; 38(7):643-6. PubMed ID: 12898356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus infection and the gastrointestinal tract.
    You DM; Johnson MD
    Curr Gastroenterol Rep; 2012 Aug; 14(4):334-42. PubMed ID: 22588614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Spector SA
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):9-12, 15-22. PubMed ID: 11363539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus infection in AIDS].
    Arrizabalaga J; Iribarren JA; Rodríguez-Arrondo F; Garde C
    Enferm Infecc Microbiol Clin; 1994; 12(6):297-311. PubMed ID: 8080868
    [No Abstract]   [Full Text] [Related]  

  • 20. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.